By vgreene, 26 March, 2020 Primary outcome: % of participants reporting severity rating on 8-point scale (1=death; 8=not hospitalized, no limits on activity)
By vgreene, 26 March, 2020 Remdesivir 200 mg IV on day 1, then 100 mg IV q24h for duration of hospitalization up to 10 days total vs placebo
By vgreene, 26 March, 2020 Randomized, double-blind trial in hospitalized adults w/ COVID-19 testing different investigational agents
By vgreene, 26 March, 2020 Upcoming: Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)